Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials

PURPOSE: Neovascular age-related macular degeneration (AMD) is the main cause of central vision loss among individuals aged 50 years or older in developed countries. The aim of this study was to review systematically the effect of bevacizumab compared to ranibizumab in patients with AMD at 1 year. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodjikian, Laurent, Decullier, Evelyne, Souied, Eric H., Girmens, Jean-François, Durand, Emilie E., Chapuis, François R., Huot, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180904/
https://www.ncbi.nlm.nih.gov/pubmed/25142373
http://dx.doi.org/10.1007/s00417-014-2764-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180904/
https://www.ncbi.nlm.nih.gov/pubmed/25142373
http://dx.doi.org/10.1007/s00417-014-2764-6

Ejemplares similares